MedTrace Logo

Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic

NCT04558645 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2020-12-29

No results posted yet for this study

Summary

During the COVID-19 pandemic, the time spent at the home of patients has increased because of national quarantine policies and patients' fear of getting sick. For this reason, in this ongoing process, patients have been unable to go to work regularly due to their chronic diseases (being on administrative leave) and their fear of going out. These reasons have prevented being physically active. The aim of the study is to evaluate the physical activity level, quality of life, glucose control, anxiety, depression, fear of hypoglycemia and loneliness perceptions of patients with type 1 diabetes mellitus during the COVID-19 pandemic period and compared with healthy controls.

Conditions

  • Type 1 Diabetes Mellitus
  • Covid19

Interventions

OTHER

Online Survey

Online surveys will be applied to all participants

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Zeliha ÇELİK, MSc · Gazi University

  • Meral BOŞNAK GÜÇLÜ, Prof · Gazi University

  • Füsun BALOŞ TÖRÜNER, Prof · Gazi University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-18
Primary Completion
2020-12-18
Completion
2020-12-26

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04558645 on ClinicalTrials.gov